Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel as first-line chemotherapy for patients with metastatic gastric cancer

被引：0
|
作者：
Xu, Rui-hua
He, Ming-ming
Zhang, Dong-sheng
Wang, Feng
Jin, Ying
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.4049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4049
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A phase II study of S-1 and oxaliplatin as first-line therapy for patients with recurrent or metastatic gastric cancer
    Kim, H.
    Lee, G.
    Kim, H.
    Lee, O.
    Hwang, I.
    Kang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial*
    Adkins, Douglas
    Ley, Jessica
    Atiq, Omar
    Powell, Steven
    Spanos, William C.
    Gitau, Mark
    Rigden, Caron
    Palka, Kevin
    Liu, Jingxia
    Oppelt, Peter
    ORAL ONCOLOGY, 2021, 115
  • [33] Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402): Final report
    Kishimoto, T.
    Imamura, H.
    Uedou, F.
    Fujitani, K.
    Iijima, S.
    Takiuchi, H.
    Imano, M.
    Shimokawa, T.
    Kurokawa, Y.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] A multi-center phase II study of S-1 plus paclitaxel as first-line therapy in patients with advanced or relapsed gastric cancer
    Lee, J. J.
    Kim, S. Y.
    Chung, H. C.
    Lee, K. H.
    Song, H. S.
    Woo, I. S.
    Hong, Y. S.
    Kang, W. K.
    Choi, J. H.
    Choi, I. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer
    Yusuke Okuma
    Yukio Hosomi
    Satoshi Takahashi
    Yoshiro Nakahara
    Kageaki Watanabe
    Makoto Nagamata
    Yusuke Takagi
    Shinichiro Mikura
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 383 - 388
  • [36] Phase II study of S-1 in combination with paclitaxel as a first-line treatment for patients with advanced/recurrent gastric cancer
    Toh, U.
    Yamana, H.
    Koufuji, K.
    Mine, T.
    Aoyagi, K.
    Miyagi, M.
    Imaizumi, T.
    Shirouzu, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Albumin-Bound Paclitaxel: A Review of Its Use for the First-Line Combination Treatment of Metastatic Pancreatic Cancer
    Sheridan M. Hoy
    Drugs, 2014, 74 : 1757 - 1768
  • [38] A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer
    Okuma, Yusuke
    Hosomi, Yukio
    Takahashi, Satoshi
    Nakahara, Yoshiro
    Watanabe, Kageaki
    Nagamata, Makoto
    Takagi, Yusuke
    Mikura, Shinichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 383 - 388
  • [39] Apatinib in combination with S-1 as first-line treatment in patients with advanced gastric cancer: A phase II clinical trial.
    Zhang, Chuantao
    Liu, Zimin
    Zhou, Na
    Zhang, Jianli
    Zhu, Jingjuan
    Lv, Hongying
    Li, Tianjun
    Hou, Helei
    Liu, Dong
    Cong, Jing
    Jiang, Man
    Liu, Kewei
    Cui, Zhumei
    Zhou, Yanbing
    Zhang, Xiaochun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [40] Albumin-Bound Paclitaxel: A Review of Its Use for the First-Line Combination Treatment of Metastatic Pancreatic Cancer
    Hoy, Sheridan M.
    DRUGS, 2014, 74 (15) : 1757 - 1768
12345